GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction US$ 27.50 Min. order: 1 piece ★★★★★ 4.5 (138 reviews) Sold : Login>>
Novo Nordisk's latest trial results for its next-generation obesity drug CagriSema disappointed investors by failing to show superior outcomes to existing drugs. ➡️ CagriSema, which includes a nascent form of weight loss US$ 27.53 Min. order: 1 piece ★★★★★ 4.2 (140 reviews) Sold : Login>>
Copper Peptides True Hair Growth Serum Based on the Anela Protocol | Ghk-cu | Ahk-cu | 30ml (1 Fl.oz) US$ 26.13 Min. order: 1 piece ★★★★★ 4.7 (183 reviews) Sold : Login>>